Dr. Gieschen on Toxicities Associated With Radiation Therapy in Prostate Cancer

Video

In Partnership With:

Holger L. Gieschen, MD, assistant professor, University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses the toxicities associated with radiation therapy in prostate cancer.

Holger L. Gieschen, MD, assistant professor, University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses the toxicities associated with radiation therapy in prostate cancer.

Acute and long-term urinary toxicities are common, says Gieschen. The proximity of the rectum to the prostate can cause rectal toxicities, such as bleeding and radiation proctitis, he adds. However, there are several ways to minimize these events. For example, hydrogel can be placed between the rectum and prostate in order to increase the distance between the 2 areas. If these toxicities do occur, which action to take will depend on severity. Usually a conservative approach is preferable to a surgical intervention in the management of these adverse events.

Not all of these toxicities are reversible, says Gieschen. For example, impotence is something that can occur, with which patients experience a decline over time that eventually becomes irreversible. However, these events are often treatable with different options.

Related Videos
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh